Loading...

Qilian International Holding Group Limited

QLINASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$5.41
$-0.20(-3.57%)

Qilian International Holding Group Limited QLI Peers

See (QLI) competitors and their performances in Stock Market.

Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
QLI$5.41-3.57%38.7M-4.92-$1.10N/A
ZTS$155.95+0.00%70.9B28.63$5.56+1.17%
TAK$15.46+0.00%48.4B66.80$0.23+3.83%
HLN$10.37+0.05%46.6B24.08$0.43+1.13%
TEVA$16.76+0.00%19.1B-14.48-$1.15N/A
ITCI$131.87+0.00%14B-180.64-$0.73N/A
NBIX$125.69+0.00%12.7B43.41$2.95N/A
RDY$15.03+0.00%12.4B19.13$0.78+0.64%
CTLT$63.48+0.00%11.5B-27.84-$2.28N/A
VTRS$8.93+0.00%10.8B-2.89-$3.18+5.26%
Showing 1 to 10 of 100 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

QLI vs ZTS Comparison

QLI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QLI stands at 38.7M. In comparison, ZTS has a market cap of 70.9B. Regarding current trading prices, QLI is priced at $5.41, while ZTS trades at $155.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QLI currently has a P/E ratio of -4.92, whereas ZTS's P/E ratio is 28.63. In terms of profitability, QLI's ROE is -0.16%, compared to ZTS's ROE of +0.51%. Regarding short-term risk, QLI is less volatile compared to ZTS. This indicates potentially lower risk in terms of short-term price fluctuations for QLI.

Stock Price Comparison

Loading...

Frequently Asked Questions

;